Merck & Co. to Acquire Harpoon Therapeutics for US$680 M
By Ayush Saxena
Pharma Deals Review: Vol 2024 Issue 2 (Table of Contents)
Published: 2 Feb-2024
DOI: 10.3833/pdr.v2024.i2.2851 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In order to expand its oncology portfolio, Merck has agreed to acquire Harpoon Therapeutics for US$680 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018